Skip to content

    Apyx Medical (APYX) stock price & financials

    View APYX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+55.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $11.49M
    $14.22M
    $9.43M
    $11.37M
    $12.88M
    +12.1%
    $19.16M
    +34.7%
    $12.49M
    +32.4%
    $13.88M
    +22.1%
    Strengthening
    Operating Profit
    -$3.63M
    -$3.05M
    -$3.05M
    -$2.57M
    -$832.0K
    +77.1%
    $11.0K
    -$911.0K
    +70.1%
    -$1.81M
    +29.8%
    Strengthening
    Net Profit
    -$4.70M
    -$4.63M
    -$4.15M
    -$3.78M
    -$1.98M
    +57.8%
    -$1.30M
    +71.9%
    -$2.11M
    +49.2%
    -$3.24M
    +14.2%
    Strengthening
    EPS
    $-0.14
    $-0.10
    $-0.09
    $-0.05
    +64.3%
    $-0.05
    +50.0%
    $-0.07
    +22.2%
    Strengthening
    Other Income
    -$1.03M
    -$1.52M
    -$1.07M
    -$1.11M
    -$1.04M
    -1.6%
    -$1.16M
    +24.0%
    -$1.09M
    -1.6%
    -$1.14M
    -2.4%
    Strengthening
    Interest
    $1.43M
    $1.65M
    $1.38M
    $1.39M
    $1.41M
    -1.3%
    $1.41M
    -14.9%
    $1.37M
    -0.5%
    $1.39M
    +0.1%
    Weakening
    Depreciation
    Profit before Tax
    -$4.66M
    -$4.57M
    -$4.12M
    -$3.69M
    -$1.88M
    +59.8%
    -$1.15M
    +74.9%
    -$2.00M
    +51.5%
    -$2.95M
    +20.1%
    Strengthening
    MarginsOPM
    -31.6%
    -21.4%
    -32.4%
    -22.6%
    -6.5%
    +79.6%
    0.1%
    -7.3%
    +77.5%
    -13.0%
    +42.5%
    Strengthening
    Tax
    -1.3%
    -1.9%
    -1.2%
    -1.3%
    -4.2%
    -222.5%
    -8.2%
    -320.5%
    -7.2%
    -500.8%
    -4.2%
    -216.5%
    Weakening
    ReturnsROIC
    5.0%
    4.9%
    4.4%
    4.0%
    2.1%
    -57.8%
    1.4%
    -71.9%
    2.2%
    -49.2%
    3.4%
    -14.2%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$16.60M$58.81M$41.91M$30.87M$10.19M$43.65M$31.74M$31.74M$27.62M
    Short-Term Investments$56.58M$39.66M
    Total Current Assets$89.83M$76.73M$66.09M$60.74M$42.97M$70.36M$56.44M$58.47M$53.16M
    Net PP&E$5.79M$6.97M$6.78M$6.70M$7.47M$7.08M$6.69M$6.59M$6.12M
    Goodwill$185.0K
    Intangibles$191.0K
    Total Assets$95.93M$84.75M$74.11M$68.72M$51.77M$79.24M$64.84M$66.84M$61.07M
    LiabilitiesTotal Current Liabilities$8.61M$12.31M$9.15M$13.21M$11.85M$12.74M$10.72M$11.70M$9.35M
    Short-Term Debt$0$0
    Long-Term Debt$0$0$33.19M$33.89M$34.85M$35.33M
    Long-Term Leases$235.0K$129.0K$0$470.0K$4.90M$4.48M$4.05M$3.83M
    Total Liabilities$8.75M$13.49M$10.25M$14.71M$13.98M$52.32M$50.51M$52.01M$49.98M
    EquityCommon Stock & APIC$34.0K$34.0K$34.0K$34.0K$35.0K$35.0K$38.0K$42.0K$42.0K
    Retained Earnings$34.22M$14.52M$2.62M-$12.55M-$35.73M-$54.45M-$77.91M-$89.12M-$94.47M
    Total Equity$87.18M$71.26M$63.72M$53.70M$37.58M$26.70M$14.21M$14.54M$10.66M
    HighlightsNet Cash / (Debt)$16.60M$10.19M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$20.88M-$18.48M-$16.07M-$10.45M-$20.28M-$5.25M-$18.05M-$8.00M-$10.13M
    Cash from Investing$29.30M$60.54M-$581.0K-$723.0K-$1.01M$6.73M-$722.0K-$1.11M-$920.0K
    Cash from Financing-$2.49M$147.0K-$73.0K$24.0K$217.0K$32.17M$6.75M$9.58M$9.61M
    SummaryCapital Expenditure-$363.0K-$1.30M-$581.0K-$723.0K-$1.01M-$533.0K-$722.0K-$1.11M-$920.0K
    Free Cash Flow-$21.24M-$19.78M-$16.65M-$11.17M-$21.29M-$5.78M-$18.77M-$9.12M-$11.05M
    FCF Margin-127.9%-70.0%-60.1%-23.0%-47.8%-11.0%-39.0%-17.2%-18.9%

    Ratios